Search Results 1041-1050 of 16883 for monoclonal antibody

1. A Study of the Safety and Effectiveness of Combined Copaxone and Estriol for Relapsing Remitting Multiple Sclerosis - Mayo Clinic

   Monoclonal antibody; T cell vaccination; Cladribine; Bone marrow transplantation; Azathioprine; Cyclophosphamide; Methotrexate; Mitoxantrone; Cyclosporin ...

2. Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer - Mayo Clinic

   ... monoclonal antibodies, other investigational agent) < 28 days prior to the first dose of study drug. Current or prior use of immunosuppressive medication ...

3. Immune globulin-slra (intravenous route) - Mayo Clinic

   Description. Immune globulin-slra injection contains antibodies that make your immune system stronger. It is used for patients who have primary humoral ...

4. Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) - Mayo Clinic

   ... antibody (including ipilimumab, tremelimumab or any other antibody, or drug specifically targeting T cell co stimulatory or immune checkpoint pathways).

5. Bone Marrow Transplant Clinical Trials - Mayo Clinic Research

   Radioactive substances linked to monoclonal antibodies, such as 90-yttrium ibritumomab tiuxetan, can bind to cancer cells and give off radiation which may help ...

6. A Study to Evaluate DS-8201a Combined with Olaparib in HER2-Expressing Cancers with Expansion in Endometrial Cancer Patients Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Endometrial Cancer - Mayo Clinic

   For this reason and because HER2 antibody conjugated to a ... monoclonal antibodies. Patients receiving any medications or substances that ...

7. Mayo Clinic Clinical Trial Helps Physician Take On Multiple Myeloma

   He had known he was at a greater risk for contracting multiple myeloma for many years because of a condition called monoclonal gammopathy of undetermined ...

8. PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti-PD-1/L1 in Patients with Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   Treatment with commercially available or investigational large molecule cancer therapies, including monoclonal antibodies (mAbs), bispecific antibodies, ...

9. Phase I Dose Escalation Study for BAY 1251152 in Patients With Advanced Cancer - Mayo Clinic

   Major surgery, significant trauma, wide-field radiotherapy, or therapy with monoclonal antibodies within 4 weeks before the first dose of study drug ...

10. A Study of Cell, Serum, and Bone Marrow Bank for Patients receiving Chimeric Antigen Receptor T Cell Therapy for the Treatment of Cancer - Mayo Clinic

    ... antibodies and the factors that may determine disease progression and treatment response. ... Plan to initiate treatment with either bi-specific antibody or CAR-T ...